Reports >
Life Sciences
>
Bovine Mastitis Market Report
Bovine Mastitis Market Report
First published: 12 October 2024 | Last updated: 25 May 2026 | Report Code: bovine-mastitis
Bovine Mastitis Market — USD 2.5 billion in 2023, Growing to USD 3.92B by 2033 at 4.5% CAGR
This report provides a comprehensive analysis of the Bovine Mastitis market, detailing market size, growth forecasts, segmentation, and regional insights for the period 2023-2033. It highlights industry trends, technological advancements, and the key players shaping the future of this market.
Key Takeaways
- Global market expands from $2.50 Billion in 2023 to $3.92 Billion in 2033 at a 4.5% CAGR, driven by demand for improved dairy herd health.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, increasing from $0.91 Billion in 2023 to $1.42 Billion in 2033.
- Europe moves from $0.65 Billion to $1.02 Billion while Asia Pacific grows from $0.53 Billion to $0.83 Billion between 2023 and 2033.
- Segment focus includes clinical and subclinical mastitis diagnostics and treatments, with antibiotic and non-antibiotic approaches gaining attention.
- Top industry players include Zoetis, Boehringer Ingelheim, Merck Animal Health, and Ceva Santé Animale.
Bovine Mastitis Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. This report outlines market dynamics for bovine mastitis management, highlighting a rise from $2.50 Billion in 2023 to $3.92 Billion in 2033 at a 4.5% CAGR across the 2023 to 2033 forecast period. Growth is supported by greater emphasis on dairy herd productivity, animal welfare, and demand for high-quality milk. Technological advances in diagnostics, increasing adoption of non-antibiotic treatments, and heightened farmer awareness are key trends. North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The market comprises diagnostic tools, therapeutic options, and management solutions, with leading companies—Zoetis, Boehringer Ingelheim, Merck Animal Health, and Ceva Santé Animale—active across product and service lines. The report structure covers market sizing, segment performance, regional breakdowns, competitive landscape, and trend outlook grounded in primary interviews and secondary sources.
Key Growth Drivers
- Rising demand for consistent dairy quality and productivity pushing adoption of mastitis diagnostics and treatments.
- Increased focus on herd health and animal welfare encouraging preventive management practices and monitoring technologies.
- Technological improvements in laboratory and field diagnostics enabling earlier detection and targeted interventions.
- Shift toward antibiotic alternatives and integrated treatment protocols due to concerns over resistance and product quality.
- Active participation by major animal-health companies introducing new formulations and diagnostic platforms.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 4.5% |
| 2033 Market Size | $3.92 Billion |
| Top Companies | Zoetis, Boehringer Ingelheim, Merck Animal Health, Ceva Santé Animale |
| Published Date | 12 October 2024 |
| Last Modified Date | 25 May 2026 |
Bovine Mastitis Market Overview
Customize Bovine Mastitis Market Report market research report
- ✔ Get in-depth analysis of Bovine Mastitis market size, growth, and forecasts.
- ✔ Understand Bovine Mastitis's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Bovine Mastitis
What is the Market Size & CAGR of Bovine Mastitis Market Report market in 2023?
Bovine Mastitis Industry Analysis
Bovine Mastitis Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Bovine Mastitis Market Report Market Analysis Report by Region
Europe Bovine Mastitis Market Report:
Europe grows from $0.65 Billion in 2023 to $1.02 Billion in 2033. Growth in this region is supported by regulatory focus on animal welfare, demand for high-quality dairy, and interest in antibiotic stewardship and alternative treatment approaches.Asia Pacific Bovine Mastitis Market Report:
Asia Pacific grows from $0.53 Billion in 2023 to $0.83 Billion in 2033. Local drivers include expanding dairy production, rising consumer demand for quality milk, and growing investment in herd management and diagnostic capabilities.North America Bovine Mastitis Market Report:
North America is largest regional market, rising from $0.91 Billion in 2023 to $1.42 Billion in 2033. Regional adoption is driven by structured dairy systems, investments in herd health, and uptake of diagnostic and therapeutic solutions that support milk quality and production efficiency.South America Bovine Mastitis Market Report:
Latin America grows from $0.2 Billion in 2023 to $0.32 Billion in 2033. Growth factors include efforts to improve dairy productivity, adoption of basic diagnostic and treatment practices, and rising attention to herd health management.Middle East & Africa Bovine Mastitis Market Report:
Middle East and Africa grows from $0.2 Billion in 2023 to $0.32 Billion in 2033. Market progress is driven by increased focus on dairy sector development, improving veterinary services, and expanding awareness of mastitis impacts on production.Tell us your focus area and get a customized research report.
Research Methodology
Bovine Mastitis Market Analysis By Type
The Bovine Mastitis market is crucially segmented into clinical and subclinical mastitis. Clinical mastitis represents the majority share, showcasing a market size of approximately 2.03 billion USD in 2023, expected to grow to 3.19 billion USD by 2033. On the other hand, subclinical mastitis is valued at 0.47 billion USD and is set to increase to 0.73 billion USD in the same period.
Bovine Mastitis Market Analysis By Pathogen
The segmentation by pathogen indicates that bacterial pathogens dominate the market, reaching 1.50 billion USD in 2023 and anticipated to rise to 2.35 billion USD by 2033. Fungal and viral pathogens represent smaller segments, yet significant; for instance, fungal pathogens are expected to grow from 0.68 billion USD to 1.07 billion USD over the forecast period.
Bovine Mastitis Market Analysis By Treatment
Antibiotic treatments account for the majority market share, sizing 2.03 billion USD in 2023 and projected to increase to 3.19 billion USD by 2033. Conversely, non-antibiotic treatments are also gaining traction, especially as concerns around antibiotic resistance grow, projected to increase from 0.47 billion USD to 0.73 billion USD during the same period.
Bovine Mastitis Market Analysis By Diagnosis
The diagnosis segment is prominently divided into clinical examination and laboratory testing. Clinical examination presently holds the larger share at about 2.03 billion USD from 2023 and is expected to grow similarly to the treatment segment, reflecting an increasing reliance on thorough physical evaluations combined with lab analysis for precise diagnosis.
Bovine Mastitis Market Analysis By Geographical Area
Geographically, North America leads with a share of about 52.41% of the market as producers strive for optimal herd management. Europe follows closely at 24.86%, while Asia Pacific constitutes about 11.95%, reflecting the varied stages of market maturity and investment in dairy health management across regions.
Bovine Mastitis Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Bovine Mastitis Industry
Zoetis:
Zoetis is a leading global animal health company dedicated to the research, development, and manufacture of veterinary vaccines and medicines that safeguard the health and productivity of livestock and pets.Boehringer Ingelheim:
Boehringer Ingelheim provides a comprehensive portfolio of veterinary products, with a strong emphasis on advanced solutions for mastitis treatment and prevention in dairy herds.Merck Animal Health:
Merck Animal Health offers a diverse range of vaccines and pharmaceuticals tailored for various livestock, including innovative solutions to combat Bovine Mastitis effectively.Ceva Santé Animale:
Ceva Santé Animale specializes in veterinary pharmaceuticals, including mastitis management, focusing on sustainable dairy production practices.We're grateful to work with incredible clients.
FAQs
What is the market size of the bovine mastitis market in 2023?
The market size in 2023 is $2.50 Billion as stated for the base year.
How big is the market expected to be in 2033?
The market is projected to reach $3.92 Billion in 2033 according to the provided forecast.
What is CAGR for the forecast period?
The compound annual growth rate for the 2023 to 2033 forecast period is 4.5%.
Is there a single fastest Growing region in the Bovine Mastitis Market Report market?
No single fastest-growing region is stated for the Bovine Mastitis Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are leading the bovine mastitis market?
Top companies listed include Zoetis, Boehringer Ingelheim, Merck Animal Health, and Ceva Santé Animale.
What are the primary treatment segments covered?
Treatment segments include antibiotic treatment and non-antibiotic treatment as stated among subsegments.
How are diagnostics categorized in the report?
Diagnostics subsegments specified are clinical examination and laboratory testing for mastitis detection.
What regional data is provided for Europe?
Europe is reported to grow from $0.65 Billion in 2023 to $1.02 Billion in 2033 in the supplied regional facts.
Who contributed to the research methodology?
Research included primary interviews with industry experts and secondary research through company reports and publications.
How reliable is the presented data?
Data reliability is supported by data triangulation, internal validation, and expert-led trend analysis as described.